Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
2002 Nov 15;2122:6195-204. doi: 10.1093/emboj/cdf625.
Show Gene links
Show Anatomy links
Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.
Hou VC
,
Lersch R
,
Gee SL
,
Ponthier JL
,
Lo AJ
,
Wu M
,
Turck CW
,
Koury M
,
Krainer AR
,
Mayeda A
,
Conboy JG
.
???displayArticle.abstract???
A physiologically important alternative pre-mRNA splicing switch, involving activation of protein 4.1R exon 16 (E16) splicing, is required for the establishment of proper mechanical integrity of the erythrocyte membrane during erythropoiesis. Here we identify a conserved exonic splicing silencer element (CE(16)) in E16 that interacts with hnRNP A/B proteins and plays a role in repression of E16 splicing during early erythropoiesis. Experiments with model pre-mRNAs showed that CE(16) can repress splicing of upstream introns, and that mutagenesis or replacement of CE(16) can relieve this inhibition. An affinity selection assay with biotinylated CE(16) RNA demonstrated specific binding of hnRNP A/B proteins. Depletion of hnRNP A/B proteins from nuclear extract significantly increased E16 inclusion, while repletion with recombinant hnRNP A/B restored E16 silencing. Most importantly, differentiating mouse erythroblasts exhibited a stage-specific activation of the E16 splicing switch in concert with a dramatic and specific down-regulation of hnRNP A/B protein expression. These findings demonstrate that natural developmental changes in hnRNP A/B proteins can effect physiologically important switches in pre-mRNA splicing.
Amendt,
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
1995, Pubmed
Amendt,
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
1995,
Pubmed
Ashiya,
A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
1997,
Pubmed
Bagga,
The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3' end pre-mRNA processing through a trans-acting factor.
1995,
Pubmed
Bai,
Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.
1999,
Pubmed
Baklouti,
Organization of the human protein 4.1 genomic locus: new insights into the tissue-specific alternative splicing of the pre-mRNA.
1997,
Pubmed
Berget,
Exon recognition in vertebrate splicing.
1995,
Pubmed
Bilodeau,
RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
2001,
Pubmed
Blanchette,
Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization.
1999,
Pubmed
Caputi,
hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
1999,
Pubmed
Chabot,
Directing alternative splicing: cast and scenarios.
1996,
Pubmed
Chan,
The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream.
1997,
Pubmed
Chasis,
Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis.
1993,
Pubmed
Conboy,
Tissue- and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1.
1991,
Pubmed
Conboy,
Hereditary elliptocytosis due to both qualitative and quantitative defects in membrane skeletal protein 4.1.
1991,
Pubmed
Conboy,
The role of alternative pre-mRNA splicing in regulating the structure and function of skeletal protein 4.1.
1999,
Pubmed
Cáceres,
Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
1994,
Pubmed
Deguillien,
Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.
2001,
Pubmed
Del Gatto,
Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon.
1995,
Pubmed
Del Gatto,
The exon sequence TAGG can inhibit splicing.
1996,
Pubmed
Del Gatto-Konczak,
hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.
1999,
Pubmed
Ding,
Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA.
1999,
Pubmed
Discher,
Mechanochemistry of protein 4.1's spectrin-actin-binding domain: ternary complex interactions, membrane binding, network integration, structural strengthening.
1995,
Pubmed
Discher,
Mechanochemistry of the alternatively spliced spectrin-actin binding domain in membrane skeletal protein 4.1.
1993,
Pubmed
Eng,
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.
1994,
Pubmed
Fu,
General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection.
1992,
Pubmed
Gascard,
Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.
1999,
Pubmed
Gee,
Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice.
2000,
Pubmed
,
Xenbase
Graham,
Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences.
1992,
Pubmed
Hellman,
Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing.
1995,
Pubmed
Hertel,
Common themes in the function of transcription and splicing enhancers.
1997,
Pubmed
Horne,
Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin.
1993,
Pubmed
Huang,
Genomic structure of the locus encoding protein 4.1. Structural basis for complex combinational patterns of tissue-specific alternative RNA splicing.
1993,
Pubmed
Kan,
Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor.
1999,
Pubmed
Koury,
Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation.
1984,
Pubmed
Koury,
Cytoskeletal distribution and function during the maturation and enucleation of mammalian erythroblasts.
1989,
Pubmed
König,
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.
1998,
Pubmed
Lander,
Initial sequencing and analysis of the human genome.
2001,
Pubmed
Liu,
Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins.
1998,
Pubmed
Luque,
An alternative domain determines nuclear localization in multifunctional protein 4.1.
1998,
Pubmed
Lynch,
Synergistic interactions between two distinct elements of a regulated splicing enhancer.
1995,
Pubmed
Matter,
Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
2000,
Pubmed
Mayeda,
Mammalian in vitro splicing assays.
1999,
Pubmed
Mayeda,
Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing.
1999,
Pubmed
Mayeda,
Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
1999,
Pubmed
Mayeda,
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
1992,
Pubmed
Mayeda,
Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
1993,
Pubmed
Mayeda,
Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins.
1994,
Pubmed
Nelson,
Mechanism for cryptic splice site activation during pre-mRNA splicing.
1990,
Pubmed
Reed,
Initial splice-site recognition and pairing during pre-mRNA splicing.
1996,
Pubmed
Sawyer,
Large-scale procurement of erythropoietin-responsive erythroid cells: assay for biological activity of erythropoietin.
1987,
Pubmed
Schaal,
Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA.
1999,
Pubmed
Schischmanoff,
Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding.
1995,
Pubmed
Si,
The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
1998,
Pubmed
Siebel,
The mechanism of somatic inhibition of Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon pseudo-5' splice site control U1 snRNP binding.
1992,
Pubmed
Smith,
Alternative pre-mRNA splicing: the logic of combinatorial control.
2000,
Pubmed
Staffa,
Novel exonic elements that modulate splicing of the human fibronectin EDA exon.
1997,
Pubmed
Takakuwa,
Restoration of normal membrane stability to unstable protein 4.1-deficient erythrocyte membranes by incorporation of purified protein 4.1.
1986,
Pubmed
Tange,
The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
2001,
Pubmed
Wang,
Regulation of pre-mRNA splicing in metazoa.
1997,
Pubmed
Watakabe,
The role of exon sequences in splice site selection.
1993,
Pubmed
Winardi,
Evolutionarily conserved alternative pre-mRNA splicing regulates structure and function of the spectrin-actin binding domain of erythroid protein 4.1.
1995,
Pubmed
,
Xenbase
Yang,
The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.
1994,
Pubmed
Yew,
Expression of cytoskeletal protein 4.1 during avian erythroid cellular maturation.
1987,
Pubmed
Zhu,
Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
2001,
Pubmed
